Does PALIPERIDONE Cause Salivary hypersecretion? 149 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 149 reports of Salivary hypersecretion have been filed in association with PALIPERIDONE (paliperidone). This represents 0.4% of all adverse event reports for PALIPERIDONE.
149
Reports of Salivary hypersecretion with PALIPERIDONE
0.4%
of all PALIPERIDONE reports
7
Deaths
60
Hospitalizations
How Dangerous Is Salivary hypersecretion From PALIPERIDONE?
Of the 149 reports, 7 (4.7%) resulted in death, 60 (40.3%) required hospitalization, and 15 (10.1%) were considered life-threatening.
Is Salivary hypersecretion Listed in the Official Label?
Yes, Salivary hypersecretion is listed as a known adverse reaction in the official FDA drug label for PALIPERIDONE.
What Other Side Effects Does PALIPERIDONE Cause?
Injury (4,348)
Gynaecomastia (4,155)
Off label use (4,041)
Drug ineffective (2,812)
Weight increased (2,136)
Hospitalisation (2,066)
Abnormal weight gain (1,816)
Hyperprolactinaemia (1,427)
Schizophrenia (1,361)
Product dose omission issue (1,304)
What Other Drugs Cause Salivary hypersecretion?
CLOZAPINE (1,349)
ARIPIPRAZOLE (497)
RISPERIDONE (485)
OLANZAPINE (449)
QUETIAPINE (299)
CARBIDOPA\LEVODOPA (248)
HALOPERIDOL (216)
DIAZEPAM (185)
CLONAZEPAM (179)
LORAZEPAM (165)
Which PALIPERIDONE Alternatives Have Lower Salivary hypersecretion Risk?
PALIPERIDONE vs PALIVIZUMAB
PALIPERIDONE vs PALONOSETRON
PALIPERIDONE vs PAMIDRONATE
PALIPERIDONE vs PAMIDRONIC ACID
PALIPERIDONE vs PANCRELIPASE